Consano Bio
About Consano Bio
Consano Bio is a biotechnology company that develops biologic therapeutics for orthopedic conditions. The company focuses on creating treatments that address the biological mechanisms behind musculoskeletal diseases. Its candidate, C-1101, is an allogeneic, multi-protein therapeutic intended to deliver concentrated plasma proteins to targeted sites of disease. It conducts research and development in areas such as tissue regeneration and protein delivery systems, aiming to influence the progression of joint and bone disorders through biologically active interventions rather than symptomatic relief.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $42.7M
- Last round: Series Unknown (Mar 2026)
- Website: consanobio.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/consano-bio-8474233 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.